CURRENT FUNDING

NIH/NIAID R01AI143639 (DITTMANN)

ELF1 - Molecular mechanisms of a novel transcription factor with broad antiviral activity

The goal of this project is to characterize the transcription factor ELF1 in conferring broad antiviral activity, in vitro and in vivo. 

NIH//NIAID R21AI139374 (DITTMANN)

SERPINs as a novel family of innate antiviral molecules

The goal of this project is to identify novel members of the serine protease inhibitor family that are critical for virus restriction in a polarized human airway epithelium model. 

G. HAROLD AND LEILA Y. MATHERS CHARITABLE FOUNDATION

Identification of novel therapeutics for COVID-19

The goal of this project is to identify and characterize novel antivirals for SARS-CoV-2 infections, using in vitro and in vivo models. 

THE VILCEK FOUNDATION (VALERO-JIMENEZ)

Postdoctoral Fellowship

NIH/NIAID T32AI17647 (PRESCOTT)

Training grant

 

Dittmann laboratory
Alexandria Center for Life Sciences, West Tower
430 E 29th Street, room 313
New York, New York 10016
USA

  • LinkedIn
  • Twitter

©2018 by Dittmann laboratory. Proudly created with Wix.com